
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Washington - Two topics - metal allergies and their effect on restenosis in stents, and the debate as to whether flu shots should be denied to those with thimerosal allergies - top a list of contact dermatitis concerns, according to an expert on the condition.